Astrazeneca Plc Stock Alpha and Beta Analysis
| AZN Stock | USD 203.73 4.72 2.26% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AstraZeneca PLC. It also helps investors analyze the systematic and unsystematic risks associated with investing in AstraZeneca PLC over a specified time horizon. Remember, high AstraZeneca PLC's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AstraZeneca PLC's market risk premium analysis include:
Beta 0.47 | Alpha 0.19 | Risk 1.67 | Sharpe Ratio 0.14 | Expected Return 0.23 |
AstraZeneca PLC Quarterly Cash And Equivalents |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
AstraZeneca | Build AI portfolio with AstraZeneca Stock |
AstraZeneca PLC Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AstraZeneca PLC market risk premium is the additional return an investor will receive from holding AstraZeneca PLC long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AstraZeneca PLC. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AstraZeneca PLC's performance over market.| α | 0.19 | β | 0.47 |
AstraZeneca PLC expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AstraZeneca PLC's Buy-and-hold return. Our buy-and-hold chart shows how AstraZeneca PLC performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.AstraZeneca PLC Market Price Analysis
Market price analysis indicators help investors to evaluate how AstraZeneca PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AstraZeneca PLC shares will generate the highest return on investment. By understating and applying AstraZeneca PLC stock market price indicators, traders can identify AstraZeneca PLC position entry and exit signals to maximize returns.
AstraZeneca PLC Return and Market Media
The median price of AstraZeneca PLC for the period between Tue, Dec 2, 2025 and Mon, Mar 2, 2026 is 184.46 with a coefficient of variation of 5.21. The daily time series for the period is distributed with a sample standard deviation of 9.73, arithmetic mean of 186.57, and mean deviation of 7.4. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ISPE Announces 2026 Facility of the Year Awards Submission Finalists at the 2026 ISPE Facilities of the Future Conference | 02/04/2026 |
2 | Eli Lilly Expands Its In Vivo Ambitions, Acquiring Cell Therapy Startup Orna for up to 2.4B | 02/09/2026 |
3 | Heres What Lifted AstraZeneca PLC in Q4 | 02/12/2026 |
4 | Pharma companies venture further afield in search of RD | 02/17/2026 |
5 | JJ to invest 1 billion in new Pennsylvania plant amid US manufacturing push | 02/18/2026 |
6 | Complement C5 Inhibitors C5 Receptor Antagonists Pipeline Market Research Report 2026 Soliris and Ultomiris from AstraZeneca and Piasky Have Set the Stage for N... | 02/19/2026 |
7 | FDA Approval For AbbVieAstraZenecas Combination Treatment Could Set New Standard For Slow Growing Blood Cancer | 02/20/2026 |
8 | Acromegaly Market Poised for Significant Expansion During the Forecast Period as New Treatment Options Emerge DelveInsight | 02/23/2026 |
About AstraZeneca PLC Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AstraZeneca or other stocks. Alpha measures the amount that position in AstraZeneca PLC has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0228 | 0.0173 | 0.0218 | Price To Sales Ratio | 3.83 | 4.9 | 4.65 |
AstraZeneca PLC Upcoming Company Events
As portrayed in its financial statements, the presentation of AstraZeneca PLC's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AstraZeneca PLC's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AstraZeneca PLC's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AstraZeneca PLC. Please utilize our Beneish M Score to check the likelihood of AstraZeneca PLC's management manipulating its earnings.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 8th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with AstraZeneca PLC
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out AstraZeneca PLC Analysis, AstraZeneca PLC Valuation, AstraZeneca PLC Correlation, AstraZeneca PLC Hype Analysis, AstraZeneca PLC Volatility, AstraZeneca PLC Price History and analyze AstraZeneca PLC Performance. To learn how to invest in AstraZeneca Stock, please use our How to Invest in AstraZeneca PLC guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.